| |
|
Medical Laboratories & Research News
|
Enzo Biochem Announces Supply and Distribution Agreement with Cancer Genetics
Wed 10:00 am ET (Business Wire)
NEW YORK----Enzo Biochem, Inc. , a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
|
|
Top-Ranked Analysts
|
Provided by StarMine
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 31B | | Price
/ Earnings: | 23.9 | | Price
/ Book: | -10.4 | | Net
Profit Margin (mrq): | 7.9% | | Price
To Free Cash Flow (mrq): | 36.0 | | Return
on Equity: | 12.8% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 0.7% |
|